We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Chubb
CB
$135B
| $94K | 0.01% |
+612
| New | +$85.8K |
|
202
Hasbro
HAS
$13.2B
| $94K | 0.01% |
+1,003
| New | +$89.2K |
|
203
PVH
PVH
$4B
| $94K | 0.01% |
+1,004
| New | +$76.5K |
|
204
VF Corp
VFC
$5.63B
| $94K | 0.01% |
+1,100
| New | +$87.9K |
|
|
ALXN
205
DELISTED
Alexion Pharmaceuticals
ALXN
| $94K | 0.01% |
+603
| New | +$77.5K |
|
206
Newell Brands
NWL
$2.38B
| $93K | 0.01% |
+4,373
| New | +$85.3K |
|
207
Northwest Natural Holdings
NWN
$2.06B
| $93K | 0.01% |
+2,032
| New | +$96.2K |
|
|
SJI
208
DELISTED
South Jersey Industries, Inc.
SJI
| $93K | 0.01% |
+4,318
| New | +$93.2K |
|
|
PBCT
209
DELISTED
People's United Financial Inc
PBCT
| $93K | 0.01% |
+7,201
| New | +$86.6K |
|
210
Hershey
HSY
$35.2B
| $92K | 0.01% |
+603
| New | +$89.2K |
|
211
PepsiCo
PEP
$190B
| $92K | 0.01% |
+619
| New | +$88K |
|
212
Waste Management
WM
$90.6B
| $92K | 0.01% |
+777
| New | +$90.6K |
|
|
GAP
213
The Gap Inc
GAP
$7.23B
| $92K | 0.01% |
+4,537
| New | +$95.3K |
|
214
Eaton
ETN
$161B
| $91K | 0.01% |
+760
| New | +$85.9K |
|
215
Mondelez International
MDLZ
$79.5B
| $91K | 0.01% |
+1,561
| New | +$89.2K |
|
216
Republic Services
RSG
$64.8B
| $91K | 0.01% |
+944
| New | +$89.8K |
|
217
Stanley Black & Decker
SWK
$14.3B
| $91K | 0.01% |
+510
| New | +$90.4K |
|
|
CNSL
218
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $91K | 0.01% |
+18,529
| New | +$97.2K |
|
219
Cintas
CTAS
$81.9B
| $90K | 0.01% |
+1,016
| New | +$88.2K |
|
|
K
220
DELISTED
Kellanova
K
| $90K | 0.01% |
+1,536
| New | +$92.3K |
|
221
TE Connectivity
TEL
$59.6B
| $90K | 0.01% |
+740
| New | +$81.6K |
|
222
Bath & Body Works
BBWI
$4.06B
| $89K | 0.01% |
+2,955
| New | +$85.8K |
|
223
Corning
GLW
$119B
| $89K | 0.01% |
+2,471
| New | +$87.8K |
|
|
ENDP
224
DELISTED
Endo International plc
ENDP
| $89K | 0.01% |
+12,447
| New | +$64.9K |
|
225
Amphenol
APH
$198B
| $88K | 0.01% |
+2,696
| New | +$82.8K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.